UK markets closed
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • FTSE 250

    23,608.79
    -221.39 (-0.93%)
     
  • AIM

    1,266.98
    -5.42 (-0.43%)
     
  • GBP/EUR

    1.1661
    -0.0022 (-0.19%)
     
  • GBP/USD

    1.3681
    -0.0040 (-0.29%)
     
  • BTC-GBP

    31,117.07
    +96.69 (+0.31%)
     
  • CMC Crypto 200

    1,067.20
    -35.86 (-3.25%)
     
  • S&P 500

    4,455.48
    +6.50 (+0.15%)
     
  • DOW

    34,798.00
    +33.18 (+0.10%)
     
  • CRUDE OIL

    73.95
    +0.65 (+0.89%)
     
  • GOLD FUTURES

    1,750.60
    +0.80 (+0.05%)
     
  • NIKKEI 225

    30,248.81
    +609.41 (+2.06%)
     
  • HANG SENG

    24,192.16
    -318.82 (-1.30%)
     
  • DAX

    15,531.75
    -112.22 (-0.72%)
     
  • CAC 40

    6,638.46
    -63.52 (-0.95%)
     

Global Urinalysis Market Research Report 2021-2026 Featuring Key Players - Siemens Healthineers, F. Hoffmann-La Roche, Cardinal Health, Abbott Laboratories, and Danaher Corp

·4-min read

Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "Urinalysis Markets - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global urinalysis market size is projected to reach USD 4.9 billion by 2026 from USD 3.5 billion in 2021, at a CAGR of 7.2% during the forecast period.

Market growth is driven by factors such as the increasing burden of UTIs, diabetes, and kidney & liver diseases, the rising geriatric population and the subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests. On the other hand, the availability of refurbished urine analyzers is expected to limit market growth to a certain extent in the coming years.

The consumables accounted for the highest growth rate in the urinalysis market, by product, during the forecast period.

The urinalysis market is segmented into consumables and instruments. The consumables segment accounted for the highest growth rate in the urinalysis market in 2020. The requirement of consumables in large numbers compared to instruments the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of consumables compared to instruments.

The disease screening segment accounted for the highest CAGR.

Based on the application, the urinalysis market is segmented into disease screening and pregnancy & fertility. In 2020, the disease screening segment accounted for the highest CAGR. The increasing incidence of UTIs and kidney ailments worldwide are driving the growth of this market.

The diagnostic laboratories segment accounted for the highest CAGR.

Based on end-users, the urinalysis market is segmented into diagnostic laboratories, hospitals and clinics, home care settings, and research laboratories & institutes. In 2020, the diagnostic laboratories segment accounted for the highest CAGR. This can be attributed to the rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, the increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced urinalysis devices such as integrated devices.

Asia Pacific: The fastest-growing region urinalysis market

The global urinalysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as rising geriatric population, high burden of chronic diseases such as CKD, growing per capita income, increasing investments in the healthcare industry by key market players, expansion of private-sector hospitals to rural areas in various APAC countries, an increasing number of hospitals and clinics, and the presence of high-growth markets are driving the growth of the urinalysis market in this region.

Some of the key players in the urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), and Danaher Corporation (US).

Premium Insights

  • The Rising Adoption of Poc Diagnostics is a Key Factor Expected to Support Market Growth During the Forecast Period

  • Consumables Segment to Command the Largest Share of the Market, by Product, in 2021

  • Disease Screening to Hold the Largest Share of the Market During the Forecast Period

  • North America to Dominate the Market in 2021

Market Dynamics

Drivers

  • Increasing Burden of Utis, Diabetes, and Liver & Kidney Diseases

  • Rising Geriatric Population and the Subsequent Increase in Age-Associated Diseases

  • Increasing Adoption of Poc Urine Diagnostic Tests

Restraints

  • Availability of Refurbished Urine Analyzers

Opportunities

  • Emerging Economies

  • Technological Advancements in Urine Analyzers

Challenges

  • Changing Regulatory Landscape for the Urinalysis Market

  • Impact of COVID-19 on the Urinalysis Market

Realistic, Pessimistic, and Optimistic Scenarios

  • Urinalysis Market

  • Pricing Analysis

Patent Analysis

  • Patent Analysis of Urinalysis Products

  • Patent Analysis of Dipsticks

Trade Analysis

  • Trade Analysis for Diagnostic and Laboratory Reagents

  • Import Data for Diagnostic and Laboratory Reagents, by Country, 2016-2020 (USD Million)

  • Import Data for Diagnostic and Laboratory Reagents, by Country, 2016-2020 (Tons)

Value Chain Analysis

Ecosystem Analysis of the Urinalysis Market

  • Role in Ecosystem

Porter's Five Forces Analysis

Companies Mentioned

  • 77 Elektronika KFT.

  • Abbott Laboratories

  • Acon Laboratories, Inc.

  • Agappe Diagnostics Ltd.

  • Alphatech Scientific

  • Analyticon Biotechnologies Ag

  • Arkray, Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories

  • Biobase Group

  • Biocare Corporation

  • Bioway Biotechnology

  • Cardinal Health, Inc.

  • Contec Medical Systems Co., Ltd.

  • Danaher Corporation

  • Dialab GmbH

  • Dirui Industrial Co., Ltd.

  • EKF Diagnostics

  • Erba Mannheim

  • F. Hoffmann-La Roche

  • Genrui Biotech Inc.

  • High Technology Inc.

  • PZ Cormay Sa

  • Quantimetrix Corporation

  • Quidel Corporation

  • Randox Laboratories Ltd.

  • Rayto Life and Analytical Sciences Co., Ltd.

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

  • Siemens Healthineers Ag

  • Spinreact S.A.

  • Sysmex Corporation

  • Teco Diagnostics

  • Thermo Fisher Scientific Inc.

  • Urit Medical Electronic Group Co., Ltd.

  • YD Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/bvfhui

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting